{ "as_of": "2026-11-06", "cmr": "uk-cm-kg/AIM/GDR", "fence": "The page is the record's research on the issuer — no analyst, no rating, no view.", "markdown": "The page is the record's research on the issuer — no analyst, no rating, no view.\n\n# GENEDRIVE PLC (AIM: GDR) — research page\n\nAs of 2026-11-06 · uk-cm-kg · record version 1\n\n## Identity and listing\n\nThe issuer is GENEDRIVE PLC, listed on AIM under the ticker GDR. Its ISIN is GB00B1VKB244 and its LEI is 213800ZYODIRZ87Y4K14. Its security type is Corporate, its segment is ASQ1, and its sector is Pharmaceuticals and Biotechnology [201030]. Its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.\n\n## The disclosure read\n\nThe record holds 63 filings in the twelve months to 2026-11-06, across 55 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-10-28 and is of type ch_psc, 9 days before the record date. The exchange median cadence gap is 7.0 days, and the sector median cadence gap is 6.0 days. The exchange median latency is 4 days, and the sector median latency is 4.0 days. The exchange median filings figure is 33.5, and the sector median filings figure is 42.\n\n## Auditor\n\nThe auditor of record is RSM UK Audit LLP. Its location is not on the record. Auditor changes are not on the record, as this market's register has no lifecycle type map yet.\n\n## Events and halts\n\nListing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The index does not carry a halt; the issuer is listed, not halted.\n\n## Orderability\n\nFor the elective professional client category, the outcome is signal ACM-200 and is determinable. For the eligible counterparty category, the outcome is signal ACM-200 and is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.\n\n## Coverage\n\nNo research houses were found on the investor-relations pages read for the issuer. The count is 0.\n\n## Open research\n\nOpenly published research notes are on the record: two notes by Hardman & Co, dated 2018-01-18 and 2017-12-13.\n\n## Licensed\n\nLicensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.\n\n## As-of depth\n\nThe market's vintage is not sealed, and no issuer years are sealed. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.\n\n## Sources\n\n12 source pages are named on this page; every value above carries its own source page and read date in the numbers.\n\n- https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (identity.exchange)\n- https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GDR (identity.isin)\n- https://find-and-update.company-information.service.gov.uk/company/06108621 (identity.jurisdiction)\n- https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)\n- https://www.londonstockexchange.com/stock/GDR/genedrive-plc/company-page (identity.sector)\n- https://mcp.uk-cm-kg.ai/events/AIM/GDR (the disclosure lines)\n- https://marketsecurities.fca.org.uk/officiallist (the halt flag)\n- https://genedrive.com/wp-content/uploads/2025/06/Genedrive_INTERIM_REPORT_2018.pdf (the auditor)\n- https://mcp.uk-cm-kg.ai/book/aio.json (the orderability chapter)\n- https://genedrive.com/wp-content/uploads/2025/06/Hardman.pdf (open research)\n- https://genedrive.com/wp-content/uploads/2025/06/13thDecember2017HardmanResearchReport.pdf (open research)\n- https://mcp.uk-cm-kg.ai/record/AIM/GDR (the record)\n", "market": "UK", "node": "uk-cm-kg", "numbers": { "as_of_depth": { "issuer_years_sealed": [], "live_record_began": "2026-09-11", "node_history_from": null, "node_years_sealed": [], "note": "6 years are sealed in the UK store; their Replay split is not built, so the as-of door answers not_sealed and the record is the live record as of 2026-11-06", "record_version": 1, "sealed": false, "store_years_sealed_not_served": [ "2021", "2022", "2023", "2024", "2025", "2026" ] }, "auditor": { "auditor": { "read_by": "adjudicated by Claude · adjudicated by Claude", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://genedrive.com/wp-content/uploads/2025/06/Genedrive_INTERIM_REPORT_2018.pdf", "state": "filled", "value": "RSM UK Audit LLP" }, "auditor_firm_id": { "market": "UK", "state": "not_on_record" }, "auditor_location": { "market": "UK", "state": "not_on_record" }, "changes": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "cmr": "uk-cm-kg/AIM/GDR", "coverage": { "count": 0, "houses": [], "pages_checked": [], "read_by": "Perplexity sonar (search) · page read by this rail", "read_date": "2026-11-12", "since": null, "state": "none_found" }, "disclosure": { "against": { "exchange": { "issuers": 594, "median_cadence_gap_days": 7, "median_filings": 33.5, "median_latency_days": 4, "name": "AIM" }, "sector": { "issuers": 51, "median_cadence_gap_days": 6, "median_filings": 42, "median_latency_days": 4, "name": "Pharmaceuticals and Biotechnology [201030]" } }, "by_type": { "agm_record_date": 3, "ch_accounts_filed": 1, "ch_capital": 2, "ch_charge": 2, "ch_confirmation_statement": 1, "ch_officer_change": 3, "ch_psc": 2, "ch_resolution": 2, "corporate_action": 4, "director_dealing": 3, "early_warning": 9, "financial_statement": 4, "regulatory_announcement": 27 }, "cadence_median_gap_days": 4, "filing_days": 55, "filings": 63, "latency_days": 9, "latest": [ { "category": null, "date": "2026-10-28", "source": "https://find-and-update.company-information.service.gov.uk/company/06108621/filing-history/MzU1MzMxNTU4N2FkaXF6a2N4/document?format=pdf&download=0", "title": "notification of a person with significant control", "type": "ch_psc" }, { "category": null, "date": "2026-10-28", "source": "https://find-and-update.company-information.service.gov.uk/company/06108621/filing-history/MzU1MzMxNDU2MmFkaXF6a2N4/document?format=pdf&download=0", "title": "withdrawal of a person with significant control statement", "type": "ch_psc" }, { "category": null, "date": "2026-10-27", "source": "https://find-and-update.company-information.service.gov.uk/company/06108621/filing-history/MzU1MzA3MjI3MGFkaXF6a2N4/document?format=pdf&download=0", "title": "appoint person director company with name date — Mr Graham Nigel Cole; 2026-07-13", "type": "ch_officer_change" }, { "category": null, "date": "2026-10-12", "source": "https://www.investegate.co.uk/announcement/rns/genedrive--gdr/nihr-highlights-genedrive-s-rapid-genetic-test/9816859", "title": "NIHR highlights genedrive's rapid genetic test", "type": "regulatory_announcement" }, { "category": null, "date": "2026-09-10", "source": "https://www.investegate.co.uk/announcement/rns/genedrive--gdr/welsh-hospitals-extend-routine-mt-rnr1-testing/9764379", "title": "Welsh hospitals extend routine MT-RNR1 testing", "type": "regulatory_announcement" } ], "latest_filing_date": "2026-10-28", "read": "the node's event lines (list_events_since), as get_filings serves them", "source": "https://mcp.uk-cm-kg.ai/events/AIM/GDR", "window": { "from": "2025-11-06", "to": "2026-11-06" } }, "identity": { "exchange": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "AIM" }, "isin": { "read_by": "LSE instrument reference record (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GDR", "state": "confirmed", "value": "GB00B1VKB244" }, "jurisdiction": { "read_by": "Companies House REST API (company profile) (jurisdiction field)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://find-and-update.company-information.service.gov.uk/company/06108621", "state": "confirmed", "value": "England and Wales (Companies House jurisdiction field)" }, "lei": { "read_by": "GLEIF ISIN-to-LEI mapping file (daily), LEI by exact ISIN", "read_date": "2026-11-09", "read_date_basis": "the field", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download (ISIN GB00B1VKB244)", "state": "sourced", "value": "213800ZYODIRZ87Y4K14" }, "name": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "GENEDRIVE PLC" }, "sector": { "read_by": "LSE issuer profile (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/stock/GDR/genedrive-plc/company-page", "state": "sourced", "value": "Pharmaceuticals and Biotechnology [201030]" }, "security_type": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "Corporate" }, "segment": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "ASQ1" }, "ticker": { "read_by": "LSE price explorer (exchange list)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer (price-explorer feed api.londonstockexchange.com/api/v1/components/refresh, markets=AIM, categories=EQUITY, showonlylse=true)", "state": "sourced", "value": "GDR" }, "website": { "read_by": "LSE issuer profile (exchange site)", "read_date": "2026-11-06", "read_date_basis": "the record version as_of", "source": "https://www.londonstockexchange.com/stock/GDR/genedrive-plc/company-page", "state": "sourced", "value": "http://www.genedriveplc.com/" } }, "licensed": { "columns": [ "licensor", "entitlement", "title", "date", "source" ], "rows": [], "rule": "A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded." }, "lifecycle": { "delisting": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "domicile_change": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "listing": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "name_change": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" }, "segment_move": { "market": "UK", "reason": "no lifecycle type map for this register yet (SHELF-01: us and ca first)", "state": "not_on_record" } }, "market": "UK", "node": "uk-cm-kg", "numbers_hash": "sha256:c701c401f9df3e89afba1511f60bb989b27e84cf6af59c587fe778436c537a21", "open_research": { "read_date": "2026-11-12", "rows": [ { "date": "2018-01-18", "kind": "issuer-sponsored", "publisher": "Hardman & Co", "read_by": "the note's link answers (200 application/pdf); a document, not read as text", "read_date": "2026-11-12", "source": "https://genedrive.com/wp-content/uploads/2025/06/Hardman.pdf", "state": "sourced", "title": "Genedrive plc" }, { "date": "2017-12-13", "kind": "issuer-sponsored", "publisher": "Hardman & Co", "read_by": "the note's link answers (200 application/pdf); a document, not read as text", "read_date": "2026-11-12", "source": "https://genedrive.com/wp-content/uploads/2025/06/13thDecember2017HardmanResearchReport.pdf", "state": "sourced", "title": "Remodelled for growth" } ], "state": "found" }, "orderability": { "chapter_as_of": "2026-11-04", "client_categories": [ "elective professional client", "eligible counterparty" ], "outcomes": { "elective professional client": { "determinable": true, "signal": "ACM-200" }, "eligible counterparty": { "determinable": true, "signal": "ACM-200" } }, "read": { "basis": "one live read per instrument class, halt state and client category on this market; this issuer's group", "chapter": "https://mcp.uk-cm-kg.ai/book/aio.json", "door": "https://mcp.uk-cm-kg.ai/mcp", "tool": "get_orderability" }, "rule_version": "acm-68000/uk/product-governance-fca-prod-sourcebook/r1", "section": "uk.aio.v16" }, "record": { "as_of": "2026-11-06", "url": "https://mcp.uk-cm-kg.ai/record/AIM/GDR", "version": 1 }, "schema": "research-numbers v0.1 (USR-01, 2026-11-11)", "status": { "read_date": "2026-11-09", "source": "https://marketsecurities.fca.org.uk/officiallist", "value": "listed, not halted" } }, "numbers_hash": "sha256:c701c401f9df3e89afba1511f60bb989b27e84cf6af59c587fe778436c537a21", "path": "/uk/AIM/GDR", "schema": "research-page v0.1 (USR-02, 2026-11-11)", "sections": [ { "id": "identity", "text": "The issuer is GENEDRIVE PLC, listed on AIM under the ticker GDR. Its ISIN is GB00B1VKB244 and its LEI is 213800ZYODIRZ87Y4K14. Its security type is Corporate, its segment is ASQ1, and its sector is Pharmaceuticals and Biotechnology [201030]. Its jurisdiction is England and Wales (Companies House jurisdiction field). Its listing status is listed, not halted.", "title": "Identity and listing" }, { "id": "disclosure", "text": "The record holds 63 filings in the twelve months to 2026-11-06, across 55 filing days. The median gap between filing days is 4.0 days. The latest filing is dated 2026-10-28 and is of type ch_psc, 9 days before the record date. The exchange median cadence gap is 7.0 days, and the sector median cadence gap is 6.0 days. The exchange median latency is 4 days, and the sector median latency is 4.0 days. The exchange median filings figure is 33.5, and the sector median filings figure is 42.", "title": "The disclosure read" }, { "id": "auditor", "text": "The auditor of record is RSM UK Audit LLP. Its location is not on the record. Auditor changes are not on the record, as this market's register has no lifecycle type map yet.", "title": "Auditor" }, { "id": "events", "text": "Listing, delisting, name change, domicile change and segment move are not on the record, as this market's register has no lifecycle type map yet. The index does not carry a halt; the issuer is listed, not halted.", "title": "Events and halts" }, { "id": "orderability", "text": "For the elective professional client category, the outcome is signal ACM-200 and is determinable. For the eligible counterparty category, the outcome is signal ACM-200 and is determinable. The rule version is acm-68000/uk/product-governance-fca-prod-sourcebook/r1, and the chapter is as of 2026-11-04.", "title": "Orderability" }, { "id": "coverage", "text": "No research houses were found on the investor-relations pages read for the issuer. The count is 0.", "title": "Coverage" }, { "id": "open_research", "text": "Openly published research notes are on the record: two notes by Hardman & Co, dated 2018-01-18 and 2017-12-13.", "title": "Open research" }, { "id": "licensed", "text": "Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.", "title": "Licensed" }, { "id": "depth", "text": "The market's vintage is not sealed, and no issuer years are sealed. The live record began on 2026-09-11. Years 2021 through 2026 are sealed in the store but not served as of a date, and the as-of door answers not_sealed.", "title": "As-of depth" }, { "id": "sources", "text": "12 source pages are named on this page; every value above carries its own source page and read date in the numbers.", "title": "Sources" } ], "sources": [ { "for": "identity.exchange", "source": "https://www.londonstockexchange.com/live-markets/market-data-dashboard/price-explorer" }, { "for": "identity.isin", "source": "https://api.londonstockexchange.com/api/gw/lse/instruments/alldata/GDR" }, { "for": "identity.jurisdiction", "source": "https://find-and-update.company-information.service.gov.uk/company/06108621" }, { "for": "identity.lei", "source": "https://mapping.gleif.org/api/v2/isin-lei/latest/download" }, { "for": "identity.sector", "source": "https://www.londonstockexchange.com/stock/GDR/genedrive-plc/company-page" }, { "for": "the disclosure lines", "source": "https://mcp.uk-cm-kg.ai/events/AIM/GDR" }, { "for": "the halt flag", "source": "https://marketsecurities.fca.org.uk/officiallist" }, { "for": "the auditor", "source": "https://genedrive.com/wp-content/uploads/2025/06/Genedrive_INTERIM_REPORT_2018.pdf" }, { "for": "the orderability chapter", "source": "https://mcp.uk-cm-kg.ai/book/aio.json" }, { "for": "open research", "source": "https://genedrive.com/wp-content/uploads/2025/06/Hardman.pdf" }, { "for": "open research", "source": "https://genedrive.com/wp-content/uploads/2025/06/13thDecember2017HardmanResearchReport.pdf" }, { "for": "the record", "source": "https://mcp.uk-cm-kg.ai/record/AIM/GDR" } ], "title": "GENEDRIVE PLC (GDR) — research page", "writer": { "by": "Claude through the platform account, Haiku class; one pass; checked against the numbers", "engine": "claude-haiku-5-5" } }